Pieter Spee
Technik-/Wissenschafts-/F&E-Leiter bei PURE BIOLOGICS S.A.
Profil
Pieter Spee is currently the Chief Scientific Officer at Pure Biologics SA since 2023.
Prior to this, he worked as the Scientific Director-Translational Immunology at Novo Nordisk A, Chief Scientific Officer at TikoMed AB, and Chief Technology Officer at FibroTx OÜ.
He obtained his doctorate degree from the University of Leiden in 1996.
Aktive Positionen von Pieter Spee
| Unternehmen | Position | Beginn |
|---|---|---|
| PURE BIOLOGICS S.A. | Technik-/Wissenschafts-/F&E-Leiter | 26.05.2023 |
Ehemalige bekannte Positionen von Pieter Spee
| Unternehmen | Position | Ende |
|---|---|---|
| FibroTx OÜ | Technik-/Wissenschafts-/F&E-Leiter | - |
TikoMed AB
 TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018. | Technik-/Wissenschafts-/F&E-Leiter | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Ausbildung von Pieter Spee
| University of Leiden | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PURE BIOLOGICS S.A. | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| FibroTx OÜ | |
TikoMed AB
TikoMed AB Pharmaceuticals: MajorHealth Technology TikoMed AB is a Swedish pharmaceutical company that develops pharmaceutical products. The private company is based in Viken, Sweden. The company was founded by Adam Bruce, Lars Bruce. Anders Kristensson has been the CEO of the company since 2018. | Health Technology |
